FDA accepts Eisai’s BLA for LEQEMBI subcutaneous autoinjector for alzheimer’s disease treatment Read more
Pharma sector gears up for Budget 2025-26; urges for strong regulatory framework and faster approval pathways Read more
Lupin launches Minzoya (Levonorgestrel and Ethinyl Estradiol Tablets, USP and Ferrous Bisglycinate Tablets) in the US Read more
Pharma MSMEs ask for condition-free time frame of 2-3 years to implement revised Schedule M Read more